Curis Inc. (NASDAQ: CRIS)
$3.3400
+0.0900 ( 0% ) 14.4K
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Market Data
Open
$3.3400
Previous close
$3.2500
Volume
14.4K
Market cap
$27.52M
Day range
$3.1400 - $3.3100
52 week range
$3.0500 - $17.4900
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | May 23, 2024 |
| 4 | Insider transactions | 1 | May 23, 2024 |
| 4 | Insider transactions | 1 | May 23, 2024 |
| 4 | Insider transactions | 1 | May 23, 2024 |
| 8-k | 8K-related | 28 | May 14, 2024 |
| 10-q | Quarterly Reports | 60 | May 07, 2024 |
| 8-k | 8K-related | 15 | May 07, 2024 |
| ars | Annual reports | 1 | Apr 10, 2024 |
| def | Proxies and info statements | 6 | Apr 10, 2024 |
| pre | Proxies and info statements | 6 | Mar 29, 2024 |